DIRECTOR Stephen Glover
DIRECTOR Gregory Freitag
To approve an amendment to the Third Amended and Restated PDS Biotechnology Corporation 2014 Equity Incentive Plan.
To ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.
To approve, by non-binding, advisory vote, the compensation of our named executive officers.